Company Filing History:
6 out of 12 
3 out of 75 
2 out of 21 
Years Active: 2020-2025
Title: Inventor Spotlight: Christian Ellinger
Introduction
Christian Ellinger, a distinguished inventor based in Munich, Germany, has made significant contributions to the field of immunotherapy. With a remarkable portfolio of seven patents, he has advanced the methodologies related to T cell therapies, thereby enhancing the capabilities of modern medical treatments.
Latest Patents
Ellinger's latest patents reflect his focus on innovative techniques in immunotherapy. One of his notable inventions is a method for detecting new immunogenic T cell epitopes and isolating new antigen-specific T cell receptors using an MHC cell library. This invention is particularly relevant to adoptive T cell therapy, T cell receptor gene therapy, and vaccination strategies. It describes a novel approach to preparing nucleic acids encoding TCR alpha and beta chain constructs specific for antigens presented on major histocompatibility complex (MHC) molecules. The method involves isolating T cells from donors and exposing them to a library of artificial antigen-presenting cells, allowing for the identification and development of TCR constructs that can be utilized in therapeutic applications for conditions such as cancer, viral infections, and autoimmune diseases.
Another patent by Ellinger covers HA-1 specific T cell receptors, focusing on an isolated TCR specific for a particular allelic variant of the minor histocompatibility antigen 1 (HA-1). This patent includes a variety of applications, including multivalent TCR complexes and potential medical uses aimed at improving patient outcomes in immunotherapy.
Career Highlights
Christian Ellinger has a commendable professional background, having worked with notable companies in the field of immunotherapy. His affiliations include Medigene Immunotherapies GmbH, a company known for its pioneering efforts in T cell therapy, and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, which is dedicated to innovative biomedical research. These experiences have undoubtedly enriched his expertise and contributed to his successful patent filings.
Collaborations
Throughout his career, Ellinger has collaborated with several accomplished professionals, including Dolores Schendel and Carina Wehner. These collaborations have facilitated the exchange of knowledge and ideas, furthering advancements in T cell receptor research and immunotherapy.
Conclusion
Christian Ellinger stands out as an influential inventor in the realm of immunotherapy. His seven patents showcase his dedication to advancing medical treatment through innovative approaches to T cell therapy. With a solid foundation in research and collaboration, Ellinger continues to play a vital role in the fight against various diseases, paving the way for future breakthroughs in immunology.